<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01441856</url>
  </required_header>
  <id_info>
    <org_study_id>NL36215.068.11</org_study_id>
    <nct_id>NCT01441856</nct_id>
  </id_info>
  <brief_title>The ORANGE II PLUS - Trial: Open Versus Laparoscopic Hemihepatectomy</brief_title>
  <official_title>The ORANGE II PLUS - Trial: an International Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Hemihepatectomies.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Raffaele University Hospital, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Derriford Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Elizabeth Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Newcastle-upon-Tyne Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Free Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital Groeninge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jessa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Aachen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The added value of the laparoscopic hemihepatectomy compared to the open hemihepatectomy has
      never been studied in a randomized controlled setting. Therefore, the multicenter
      international ORANGE II PLUS - trial has been constructed and will provide evidence on the
      merits of laparoscopic versus open hemihepatectomy in terms of time to functional recovery,
      hospital length of stay, intraoperative blood loss, operation time, resection margin, time to
      adjuvant chemotherapy initiation, readmission percentage, (liver-specific) morbidity, quality
      of life, body image, reasons for delay of discharge after functional recovery, long term
      incidence of incisional hernias, hospital and societal costs during one year and overall
      five-year survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Liver resection for colorectal metastasis is the only potentially curative therapy and has
      become the standard of care in appropriately staged patients, offering 5-year survival rates
      of approximately 35-40%. Also for symptomatic benign lesions and those of uncertain nature or
      large size, liver resection is a widely accepted treatment. Open hepatectomy (OH) is the
      current standard of care for the management of primary and secondary malignancies. Although
      the feasibility of laparoscopic hepatectomy (LH) has been established, only select centres
      have used this technique as their primary modality.

      Laparoscopic liver resection was first reported in 1991. Over the last decade the method has
      gained wide acceptance for various liver resection procedures. Multiple retrospective case
      series and reviews comparing open with laparoscopic liver resection indicate that
      laparoscopic liver resection can be applied safely for both malignant and benign liver
      lesions. Laparoscopic liver resection has been associated with shorter hospital length of
      stay, reduced intraoperative blood loss, less postoperative pain, earlier recovery and better
      quality of life. Initially the left lateral segments of the liver were chosen for anatomic
      laparoscopic resection with good results. Many liver centres worldwide are currently adopting
      laparoscopic surgery for resection of anterior segments, but relatively low volumes to
      operate on, a significant learning curve and lack of evidence restrict the majority of liver
      surgeons to further adopt and disseminate this technique.

      Recently, indications for resectability have been broadened by new (neo)adjuvant
      chemotherapies and (radio)embolisation techniques. A new impulse for the laparoscopic
      management of liver lesions came after the first reports of laparoscopic hemihepatectomies.
      Major hepatic resections can be technically demanding and hold an increased risk for
      morbidity. It was demonstrated that in expert hands major anatomical laparoscopic liver
      resections were feasible with good efficacy and safety. Expert liver centers are already
      performing laparoscopic (extended) hemihepatectomies. Currently, in European centers, a
      median hospital length of stay of 6.0 to 13.1 and 3.5 to 10.0 days is observed after
      respectively open and laparoscopic hepatic resection. In expert hands median duration of
      admission after major hepatic resection varies between 6 - 12.5 for open and 4 - 8.2 for
      laparoscopic surgery. However, reports are scarce and level 1 evidence on this matter is
      still to be presented.

      Within the framework of optimising postoperative recovery, broader indications for resection
      and further adoption of laparoscopic liver surgery there is a need for a randomized
      trial.Regarding postoperative care, enthusiasm has arisen for the Enhanced Recovery After
      Surgery (ERAS®) program. This multimodal program, derived from Kehlet's 1990's pioneer work
      in the multimodal surgical care field, involves optimization of several aspects of the
      perioperative management of patients undergoing major abdominal surgery. In patients
      undergoing segmental colectomy, the ERAS® -program enabled earlier recovery and consequently
      shorter hospital length of stay. Furthermore, a reduction of postoperative morbidity in
      patients undergoing intestinal resection was reported. These results stimulated liver
      surgeons of the ERAS® group (Maastricht, Edinburgh and Tromsö) to adapt the ERAS®-program to
      patients undergoing open liver resection. Van Dam et al. found a significantly reduced
      hospital length of stay after open liver resection when patients were managed within a
      multimodal ERAS®-program. Besides a reduction of median total hospital length of stay from 8
      to 6 days (25%), the data also suggested that a further reduction of stay could be possible
      as there was a delay between recovery and actual discharge of the patients. Moreover, Stoot
      et al. showed - retrospectively - a further reduction in length of stay from 7 days to 5 days
      when patients were operated laparoscopically and managed within an ERAS®-program. In this
      study there was also a delay between recovery and actual discharge of the patients. Earlier,
      Maessen et al. reported a median delay to discharge of 2 days after patients had functionally
      recovered from colonic surgery managed within an ERAS®-program. This delay is often linked to
      social problems, problems in homecare support or logistic problems.

      The added value of the laparoscopic hemihepatectomy compared to the open hemihepatectomy has
      never been studied in a randomized controlled setting. Therefore, the multicenter
      international ORANGE II PLUS - trial has been constructed and will provide evidence on the
      merits of laparoscopic versus open hemihepatectomy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to functional recovery</measure>
    <time_frame>expected average of 4-10 days</time_frame>
    <description>Time until a patient is functionally recovered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Total length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission percentage</measure>
    <time_frame>1 year</time_frame>
    <description>Total percentage of patients being readmitted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morbidity</measure>
    <time_frame>1 year</time_frame>
    <description>Total morbidity during one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite endpoint of liver specific morbidity</measure>
    <time_frame>1 year</time_frame>
    <description>Composite endpoint of liver specific morbidity(intra-abdominal bleeding, intra-abdominal abcess, ascites, postresectional liver failure, intra-operative mortality, bile leakage)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term incidence of incisional hernia</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of incisional hernia after 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>QoL assessment (QLQ-C30 + LM 21) during one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body image and cosmesis</measure>
    <time_frame>1 year</time_frame>
    <description>Influence of intervention on body image and cosmesis during one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for delay in discharge after functional recovery</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative blood loss</measure>
    <time_frame>During procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative time</measure>
    <time_frame>Surgical time from incision to closure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resection margin</measure>
    <time_frame>During pathology assessment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to adjuvant chemotherapy initiation</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital and societal cost</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-year overall survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Liver Lesions Requiring Hemihepatectomy</condition>
  <arm_group>
    <arm_group_label>Open or Laparocopic Left</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open or Laparoscopic left hemihepatectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open or Laparoscopic Right</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open or Laparoscopic right hemihepatectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective registry</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prospective registry of patients that cannot be randomized (both open and laparoscopic left + right hemihepatectomy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open or Laparoscopic left hemihepatectomy</intervention_name>
    <description>Patients in this arm will undergo a left hemihepatectomy within an Enhanced Recovery After Surgery Program.</description>
    <arm_group_label>Open or Laparocopic Left</arm_group_label>
    <arm_group_label>Prospective registry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open or Laparoscopic right hemihepatectomy</intervention_name>
    <description>Patients in this arm will undergo a right hemihepatectomy within an Enhanced Recovery After Surgery Program.</description>
    <arm_group_label>Open or Laparoscopic Right</arm_group_label>
    <arm_group_label>Prospective registry</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring open or laparoscopic left / right hemihepatectomy, with or without
             the need for one additional hepatic wedge resection or metastasectomy, for accepted
             indications.

          -  Able to understand the nature of the study and what will be required of them.

          -  Men and non-pregnant, non-lactating women age 18 years and older.

          -  BMI between 18-35.

          -  Patients with ASA I-II-III.

        Exclusion Criteria:

          -  Inability to give written informed consent.

          -  Patients undergoing liver resection other than left or right hemihepatectomy, with or
             without the need for one additional hepatic wedge resection or metastasectomy.

          -  Patients with hepatic lesion(s), that are located with insufficient margin from
             vascular or biliary structures to be operated laparoscopically.

          -  Patients with ASA IV-V.

          -  Repeat hepatectomy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R.M. van Dam, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>R.S. Fichtinger, MD</last_name>
    <phone>+31614921200</phone>
    <email>robert.fichtinger@mumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>R.M. van Dam, MD PhD</last_name>
    <phone>+31433877489</phone>
    <email>r.van.dam@mumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erasmus Hospital</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>V. Lucidi, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>V. Lucidi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>G. Katsanos, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R.I. Troisi, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>R.I. Troisi, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>V. Scuderi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jessa Hospital</name>
      <address>
        <city>Hasselt</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G. Sergeant, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>G. Sergeant, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Groeninge</name>
      <address>
        <city>Kortrijk</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. D'Hondt, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>M. D'Hondt, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>I. Boscart</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>U.P. Neumann, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>U.P. Neumann, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>F. Ulmer, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>L. Aldrighetti, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>L. Aldrighetti, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>F. Ratti, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M.G. Besselink, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>M.G. Besselink, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>P.J. Tanis, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center+</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. S. Fichtinger, MD MSc</last_name>
    </contact>
    <investigator>
      <last_name>R.M. van Dam, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>R.S. Fichtinger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Oslo</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Å.A. Fretland, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>B.E. Edwin, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Å.A. Fretland, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Sutcliffe, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>R. Sutcliffe, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>P. Marudanayagam, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>D. Bennett, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>K.V. Menon, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>K.V. Menon, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>A. Ayers, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S. A. White, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>S. A. White, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>S. M. Robinson, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Plymouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S. Aroori, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>S. Aroori, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>C. Briggs, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.N. Primrose, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>M. Abu Hilal, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>A.S. Takhar, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>T.H. Armstrong, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Z.R. Hamady, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2011</study_first_submitted>
  <study_first_submitted_qc>September 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2011</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Open</keyword>
  <keyword>Laparoscopic</keyword>
  <keyword>Hemihepatectomy</keyword>
  <keyword>Enhanced Recovery After Surgery</keyword>
  <keyword>Functional recovery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

